| Serial Number | 97877313 |
| Word Mark | THANKTIVA |
| Filing Date | Friday, April 7, 2023 |
| Status | 807 - SU - NON-FINAL ACTION - MAILED |
| Status Date | Tuesday, October 1, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, December 12, 2023 |
| Goods and Services | Pharmaceutical preparations and substances for the treatment of immunologic dysfunction, cancer, autoimmune diseases, and infectious diseases; pharmaceutical preparations and substances for the prevention of immunologic dysfunction, cancer, autoimmune diseases, and infectious diseases; pharmaceutical and biological preparations for use in targeted immunotherapy for the treatment and prevention of immunologic dysfunction, cancer, autoimmune diseases, and infectious diseases; biological preparations for the treatment and prevention of immunologic dysfunction, cancer, autoimmune diseases and infectious diseases in the fields of immunotherapy and immuno-oncology; anti-infectives for medical use for the treatment and prevention of immunologic dysfunction, autoimmune diseases and infectious diseases |
| Goods and Services | Medical services; medical information; providing a website featuring medical information in the fields of pharmaceuticals, immunotherapy, immuno-oncology, cancer, autoimmune diseases, and infectious diseases; providing medical information relating to pharmaceuticals, immunotherapy, immuno-oncology, and the treatment and prevention of cancer, autoimmune diseases, and infectious diseases |
| Goods and Services | Medical and pharmaceutical research and development services; medical and scientific research in the fields of pharmaceuticals, immunotherapy, immuno-oncology, and the treatment and prevention of cancer, autoimmune diseases, and infectious diseases; product development in the fields of pharmaceuticals, immunotherapy, immuno-oncology, and the treatment and prevention of cancer, autoimmune diseases, and infectious diseases |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, May 2, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | Tuesday, April 23, 2024 |
| First Use In Commerce Date | Tuesday, April 23, 2024 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, May 2, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | Tuesday, April 23, 2024 |
| First Use In Commerce Date | Tuesday, April 23, 2024 |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, May 2, 2023 |
| Primary Code | 044 |
| First Use Anywhere Date | Tuesday, April 23, 2024 |
| First Use In Commerce Date | Tuesday, April 23, 2024 |
| Party Name | ImmunityBio, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92121 |
| Party Name | ImmunityBio, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92121 |
| Event Date | Event Description |
| Tuesday, May 2, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, April 11, 2023 | NEW APPLICATION ENTERED |
| Wednesday, November 1, 2023 | ASSIGNED TO EXAMINER |
| Tuesday, November 7, 2023 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, November 7, 2023 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, November 7, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, November 7, 2023 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, November 7, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, November 22, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, December 12, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, December 12, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, February 6, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Wednesday, July 17, 2024 | USE AMENDMENT FILED |
| Wednesday, July 17, 2024 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, July 17, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, July 17, 2024 | SOU EXTENSION 1 FILED |
| Thursday, September 19, 2024 | STATEMENT OF USE PROCESSING COMPLETE |
| Thursday, September 19, 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Tuesday, October 1, 2024 | NON-FINAL ACTION E-MAILED |
| Tuesday, October 1, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, October 1, 2024 | SU - NON-FINAL ACTION - WRITTEN |
| Wednesday, July 17, 2024 | SOU EXTENSION 1 GRANTED |
| Wednesday, July 17, 2024 | TEAS STATEMENT OF USE RECEIVED |